| Pharmaceutical active ingredients: |
| Dapsone |
| Available forms, composition and doses of Sulfon-Mere: |
| N / A |
| Sulfon-Mere medical category: |
| Human:Acne treatment preparationsAntileproticsMiscellaneous antimycobacterials |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D10AX05 - DapsoneJ04BA02 - Dapsone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sulfona | Dapsone | Zimaia Laboratorio; Orsade |
| Sulfonamid Spuman | Sulfanilamide | Sankyo |
| Sulfonamide P | Sulfanilamide | Unidentified Pharmaceutical Company |
| Sulfonamides Duplex | Sulfadiazine; Sulfamerazine | Eli Lilly |
| Sulfone UCB | Dapsone | Unidentified Pharmaceutical Company |
| Sulfonsol | Sulfadiazine | Unidentified Pharmaceutical Company |
| Sulfo-Olbad Cordes | Bituminous Shale Oil; Soya Oil | Ichthyol-Gesellschaft Cordes, Hermanni; Medinova |
| Sulfopal | Sodium Humate; Sulfur Colloidal | Bastian-Werk |
| Sulfopecticept Liquid | Ammonium Chloride; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Menthol; Phenylephrine Hydrochloride; Sulfadiazine | Sanol |
| Sulfopecticept Tablets | Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride; Sulfadiazine | Sanol |